Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11 (2011), Pages 1781-1787
http://dx.doi.org/10.1100/2011/409140
Research Article

Pregnancy Rates with Recombinant versus Urinary Human Chorionic Gonadotropin in In Vitro Fertilization: An Observational Study

1Infertility Center of Buda, Szt János Hospital, H-1125 Budapest, Hungary
2Research Group of Pediatrics and Nephrology, Hungarian Academy of Sciences, H-1083 Budapest, Hungary
3Department of Laboratory Medicine, Semmelweis University, H-1083 Budapest, Hungary
4Department of Obstetrics and Gynecology, Mór Kaposi University Teaching Hospital, H-7400 Kaposvár, Hungary

Received 14 September 2011; Accepted 12 October 2011

Academic Editor: Takeshige Otoi

Copyright © 2011 József Zeke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ludwig, K. J. Doody, and K. M. Doody, “Use of recombinant human chorionic gonadotropin in ovulation induction,” Fertility and Sterility, vol. 79, no. 5, pp. 1051–1059, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. H. G. Al-Inany, M. Aboulghar, R. Mansour, and M. Proctor, “Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception,” Cochrane Database of Systematic Reviews, vol. 2, Article ID CD003719, 2005. View at Google Scholar · View at Scopus
  3. A. Farrag, A. Costantini, C. Manna, and G. Grimaldi, “Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI,” Journal of Assisted Reproduction and Genetics, vol. 25, no. 9-10, pp. 461–466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Kovacs, T. Kovats, A. Bernard, J. Zadori, G. Szmatona, and S. G. Kaali, “Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization,” Fertility and Sterility, vol. 90, no. 6, pp. 2133–2137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. G. Papanikolaou, C. Bourgain, H. Fatemi et al., “Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study,” Reproductive BioMedicine Online, vol. 21, no. 1, pp. 50–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. G. Papanikolaou, H. Fatemi, M. Camus et al., “Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial,” Fertility and Sterility, vol. 94, no. 7, pp. 2902–2904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Lass, “Investigation of the infertile couple for assisted conception,” in A Textbook of In Vitro Fertilisation and Assisted Reproduction, P. R. Brinsden, Ed., chapter 2, pp. 13–26, Parthenone Publishing Group, Carnforth, UK, 1999. View at Google Scholar
  8. J. Zeke, K. Kanyó, R. Kriston, and E. Varga, “Experiences gained in IVF cycles using antagonist and long protocol,” Magyar Noorvosok Lapja, vol. 69, no. 2, pp. 133–137, 2006 (Hungarian). View at Google Scholar
  9. Centers for Disease Control and Prevention website, Assisted Reproductive Technology (ART) Report, http://apps.nccd.cdc.gov/art/Apps/FertilityClinicReport.aspx.
  10. M. L. Sneed, M. L. Uhler, H. E. Grotjan, J. J. Rapisarda, K. J. Lederer, and A. N. Beltsos, “Body mass index: impact on IVF success appears age-related,” Human Reproduction, vol. 23, no. 8, pp. 1835–1839, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Dokras, L. Baredziak, J. Blaine, C. Syrop, B. J. VanVoorhis, and A. Sparks, “Obstetric outcomes after in vitro fertilization in obese and morbidly obese women,” Obstetrics & Gynecology, vol. 108, no. 1, pp. 61–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. L. R. Nelson and S. E. Bulun, “Estrogen production and action,” Journal of the American Academy of Dermatology, vol. 45, no. 3, pp. S116–S124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. K. Martin-Johnston, M. L. Uhler, H. E. Grotjan, A. S. Lifchez, J. M. Nani, and A. N. Beltsos, “Lower chance of pregnancy with repeated cycles with in vitro fertilization,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 54, no. 2, pp. 67–72, 2009. View at Google Scholar · View at Scopus
  14. D. Bodri, S. K. Sunkara, and A. Coomarasamy, “Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis,” Fertility and Sterility, vol. 95, no. 1, pp. 164–169, 2011. View at Publisher · View at Google Scholar · View at Scopus